Both Noom and Ro provide access to GLP-1 treatments, but they differ in how they help you build sustainable habits for lasting results
No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia
Cardiovascular Protection: The drug significantly lowered blood pressure and improved cholesterol, even in patients who were previously resistant to standard treatments
Patients involved in GLP-1 lawsuits allege that these drugs caused debilitating health effects linked to delayed gastric emptying, intestinal obstruction, chronic vomiting, severe abdominal pain, dehydration, malnutrition, and sudden vision loss
But do they truly measure up to the effectiveness of GLP-1 injections
The Future of Metabolic Medicine in India With rising rates of obesity, insulin resistance, and metabolic syndrome in urban India, therapies like retatrutide represent a shift toward precision metabolic modulation